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Decreased pulmonary expression of Forkhead Box f1 (Foxf1) transcription factor was associated with lethal alveolar
emorrhage in 55% of the Foxf1 1/2 newborn mice. The severity of the pulmonary abnormalities correlates with the levels
f Foxf1 mRNA. Defects in alveolarization and vasculogenesis were observed in subsets of the Foxf1 1/2 mice with
elatively low levels of expression from the normal Foxf1 allele. Lung hemorrhage was coincident with disruption of the
esenchymal–epithelial cell interfaces in the alveolar and bronchiolar regions of the lung parenchyma and was associated
ith increased apoptosis and reduced surfactant protein B (SP-B) expression. Finally, the lung defect associated with the
oxf1 1/2 mutation was accompanied by reduced expression of vascular endothelial growth factor (VEGF), the VEGF
eceptor 2 (Flk-1), bone morphogenetic protein 4 (Bmp-4), and the transcription factors of the Brachyury T-Box family
Tbx2–Tbx5) and Lung Kruppel-like Factor. Reduction in the level of Foxf1 caused neonatal pulmonary hemorrhage and
bnormalities in alveologenesis, implicating this transcription factor in the regulation of mesenchyme–epithelial interac-
ion critical for lung morphogenesis. © 2001 Academic Press
Key Words: winged-helix transcription factor; HFH-8; Freac-1; Foxf1; alveolar endothelial cell; Type I epithelial cell;
bronchiolar smooth muscle cells; PECAM-1.(
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Development of the mouse lung begins at Day 9.5 post-
coitum (p.c.) as the lung buds arise from the laryngotracheal
groove of the foregut. The endodermally developing buds
invade the splanchnic mesenchyme and undergo dichoto-
mous branching regulated by mesenchymal–epithelial in-
teractions, which induce cellular proliferation, migration,
and differentiation (Warburton et al., 2000). After the con-
ducting airways are formed, lung growth continues by
sacculation and septation of peripheral saccules to form
alveoli. The alveoli are lined by specialized epithelial cells
1 To whom correspondence should be addressed at University of
Illinois at Chicago, College of Medicine, Department of Molecular
Genetics (M/C 669), 900 S. Ashland Ave, Rm. 2220 MBRB, Chi-ecago, IL 60607-7170. Fax: (312) 355-4010. E-mail: robcosta@uic.edu.
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All rights of reproduction in any form reserved.Type I and Type II cells) and are vascularized by an
xtensive capillary bed to facilitate gas exchange. The
uxtaposition of alveolar Type I epithelial cells with endo-
helial cells of the pulmonary vasculature facilitates effi-
ient gas exchange with the circulatory system. Branching
orphogenesis of the lung depends on mesenchymal–
pithelial interactions mediated by various signaling mol-
cules that regulate the process of lung morphogenesis
Costa et al., 2001). A number of polypeptide factors have
een implicated in normal and abnormal lung morphogen-
sis, including Sonic hedgehog (Shh) (Bellusci et al., 1997a;
itingtung et al., 1998), keratinocyte growth factor (KGF)
Simonet et al., 1995), bone morphogenetic protein 4
Bmp-4) (Bellusci et al., 1996; Weaver et al., 1999), hepato-
yte growth factor (HGF) (Ohmichi et al., 1998), fibroblast
rowth factor 10 (FGF10) (Bellusci et al., 1997b; Sekine
t al., 1999), and the FGF receptor (Peters et al., 1994;
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490 Kalinichenko et al.Tichelaar et al., 2000). Likewise, transcription factors, in-
cluding TTF-1, GATA-6, HNF-3b, and HFH-4 have been
mplicated in lung morphogenesis, cell differentiation, and
ung-selective gene expression (Costa et al., 2001; Perl et
l., 1999).
The lung mesenchyme undergoes vasculogenesis (forma-
ion of new blood vessels de novo) and angiogenesis
branching of preexisting blood vessels) in a process requir-
ng appropriate levels of vascular endothelial growth factor
VEGF) (Breier et al., 1992; Risau, 1997). Targeted disrup-
ion of the Vegf gene produces an embryonic lethal pheno-
ype displaying impaired blood-island formation and de-
ayed endothelial cell differentiation, leading to abnormal
lood vessel development (Carmeliet et al., 1996; Ferrara et
l., 1996). Interestingly, Vegf 1/2 mouse embryos also
xhibit abnormalities in blood vessels, indicating a require-
ent for wild type levels of VEGF to mediate proper
ormation of the vasculature. VEGF is the ligand for the
ms-like receptor tyrosine kinase (Flt-1; VEGF-R1) and the
eceptor tyrosine kinase Flk-1 (VEGF-R2), the latter of
hich is expressed in the splanchnic mesenchyme of the
eveloping lung. Overexpression of VEGF in the respiratory
pithelium stimulated vasculogenesis in transgenic mouse
ungs, but resulted in aberrant vessel formation and in-
reased expression of Flk-1 (Zeng et al., 1998).
Likewise, Flk1 2/2 mice display inhibition of vasculo-
enesis and formation of angioblast cells in the blood
slands (Shalaby et al., 1995), whereas disruption of the Flt1
ene allows the formation of angioblasts but inhibits their
ssembly into functional blood vessels (Fong et al., 1995).
ther receptor tyrosine kinases involved in blood vessel
ormation and vascular remodeling include the Tie-1 and
ie-2 (TEK) genes, which are expressed in the lateral and
xtraembryonic mesoderm of the developing embryo (Du-
ont et al., 1995; Korhonen et al., 1994; Puri et al., 1995;
ato et al., 1995; Yancopoulos et al., 2000). Identification of
ranscription factors expressed in the fetal lung mesen-
hyme that regulate the receptor tyrosine kinases involved
n formation of the lung vasculature will therefore provide
nsights regarding pulmonary vasculogenesis and angiogen-
sis during embryonic development and during repair fol-
owing lung injury.
The hepatocyte nuclear factor 3a (HNF-3a), -3b, and -3g
proteins share homology in the winged-helix/fork head
DNA binding domain (Clark et al., 1993). The forkhead
proteins were first identified as mediating transcription of
hepatocyte-specific genes (Costa et al., 1989; Lai et al.,
990; Lai et al., 1991). Subsequent promoter studies of
ulmonary epithelial-specific genes demonstrated an im-
ortant role for the HNF-3a and HNF-3b proteins in regu-
lating transcription of surfactant protein B (SP-B), SP-C, and
Clara cell secretory protein (CCSP) genes (Bingle and Gitlin,
1993; Bohinski et al., 1994; He et al., 2000; Sawaya et al.,
1993). Furthermore, HNF-3b regulates transcription of the
Nkx homeodomain transcription factor TTF-1 (Ikeda et al.,
1996), which in turn regulates transcription of the surfac-
tant protein genes (Bohinski et al., 1994; Bruno et al., 1995; F
Copyright © 2001 by Academic Press. All rightYan et al., 1995). The HNF-3/forkhead proteins are a
growing family of transcription factors that play important
roles in cellular proliferation and differentiation as well as
in organ morphogenesis (Costa et al., 2001; Kaufmann and
Knochel, 1996). Recently, the nomenclature of the winged-
helix/fork head family has been revised to Forkhead Box
(Fox) genes (Kaestner et al., 2000).
Previous in situ hybridization studies demonstrated that
Foxf1 (also known as HFH-8 or Freac-1) expression initiates
during gastrulation in a subset of mesodermal cells arising
from the primitive streak region that contributes to the
extraembryonic mesoderm and lateral mesoderm (Peterson
et al., 1997). During organogenesis Foxf1 expression is
restricted to the splanchnic mesoderm contacting the em-
bryonic gut, suggesting that it may participate in the
mesenchymal–epithelial induction of lung and gut morpho-
genesis (Mahlapuu et al., 1998; Peterson et al., 1997).
Consistent with the early expression pattern in the
extraembryonic and lateral mesoderm-derived tissues,
Foxf1 2/2 mice die in utero because of defects in mesoder-
mal differentiation and cell adhesion (Mahlapuu et al.,
2001). Their extraembryonic structures also exhibit a num-
ber of differentiation defects including defective vasculo-
genesis of yolk sac and allantois, a failure in chorioallantoic
fusion, and retarded growth of the amnion.
In the present work, we have generated a targeted disrup-
tion of the mouse Foxf1 gene in which the winged-helix
NA binding domain was replaced by an in-frame insertion
f a nuclear localizing b-galactosidase gene. Expression of
the b-galactosidase gene was under the control of the Foxf1
NA regulatory sequences, and thus staining for
b-galactosidase enzyme activity allowed identification
of Foxf1-expressing cells. Previous immunohistochemical
colocalization studies demonstrated that Foxf1-driven
b-galactosidase expression was restricted to the platelet
endothelial cell adhesion molecule-1 (PECAM-1) positive
alveolar endothelial cells and the peribronchiolar smooth
muscle cells (Kalinichenko et al., 2001).
In this study, we describe a lethal Foxf1 1/2 phenotype
n which 55% of the newborn heterozygous mice die of
evere lung hemorrhage. This newborn lethal phenotype
as correlated with heterozygous lungs displaying 20% of
ild type Foxf1 levels, suggesting that normal wild type
oxf1 expression is essential for lung morphogenesis and
unction. Interestingly, the Foxf1 1/2 lung phenotype
esembles the lethal pediatric human disease called idio-
athic pulmonary (or alveolar) hemorrhage, a common
omplication of preterm infants with respiratory distress
Rezkalla and Simmons, 1995). The Foxf1 1/2 lung defect
as associated with abnormalities in alveolar formation
nd pulmonary vasculature with disruption of the
esenchymal–epithelial cell interface between alveolar
ype I epithelial and endothelial cells and between peri-
ronchiolar smooth muscle layers and epithelial cells. An
ncrease in apoptosis was noted in peribronchiolar smooth
uscle cells in the lung parenchyma. Furthermore, the
oxf1 1/2 lung defect was associated with reduced expres-
s of reproduction in any form reserved.
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491Pulmonary Hemorrhage in Newborn Foxf1 1/2 Micesion of VEGF, Flk-1, PECAM-1, and Bmp-4 as well as the
transcription factors Brachyury or T-box factors (Tbx2–
Tbx5) and Lung Kruppel-like Factor (LKLF).
MATERIALS AND METHODS
Generation and Screening of Foxf1 Knockout Mice
Foxf1 N-terminal sequences and the winged-helix DNA binding
domain (between NcoI and NotI site) were replaced with the
nuclear localizing b-galactosidase (b-gal) LacZ gene and PGK-1
promoter-driven neomycin (Neo) gene (used for positive selection).
The remaining HFH-8 N-terminal sequences were fused in-frame
with the nuclear localizing b-gal gene, which enabled the use of
-gal to stain for Foxf1-regulated b-gal expression in heterozygous
ice (Kalinichenko et al., 2001). The PGK-1 promoter-driven
erpes simplex virus thymidine kinase (HSV-TK) gene was placed
utside of the Foxf1 gene homology region for negative selection of
onhomologous recombination during targeted embryonic stem
ES) cell selection using gancyclovir. ES cells with the appropriate
FH-8 b-galactosidase gene-targeted locus were identified and used
to generate chimeric mice, using procedures as previously de-
scribed (Clark et al., 1995) in the Transgenic Mouse Core, Univer-
sity of Cincinnati. Following digestion of ES cell DNA with NotI
and BglII, Southern blot analysis was used to discriminate between
the wild type (5.4 kb) and targeted (7.2 kb) Foxf1 alleles with a
genomic probe that lies in the 39 flanking region outside of the
Foxf1 gene targeting vector (Fig. 1). Tail DNA from the offspring of
targeted ES cell chimeric mice was used for this Southern blot
analysis to screen for the heterozygous targeted Foxf1 locus.
We also used PCR amplification of tail DNA to verify the
appropriate homologous recombination using the following prim-
ers: 59-ccggagaagccgccctactc and 59-ttgagcgcctggcatttcct for the
deleted wild type Foxf1 winged-helix sequences and 59-
ccacagtcgatgaatccagaaaag and 59-tggagaggctattcggctatgac for the
Neo gene. Heterozygous Foxf1 mice were kept as 129-J/Black Swiss
mouse background and embryos (Day 15 p.c. and Day 18.5 p.c.) and
newborn mice were used for lung RNA preparation, paraffin
embedding, or protein preparation as described previously
(Kalinichenko et al., 2001; Rausa et al., 2000). We also bred the
Foxf1-targeted locus into the Balb/c mouse strain and found ap-
proximately 50% mortality in newborn Foxf1 1/2 mice. Heterozy-
gous newborn Foxf1 mice or Day 18 embryos were divided on the
basis of the pulmonary levels of Foxf1 mRNA using RNA protec-
tion assays: either High Foxf1 levels (equal to or 90% of Foxf1
levels in wt lungs) or Low Foxf1 levels (between 20 and 30% of the
Foxf1 levels in wt lungs). The Low Foxf1 1/2 mouse lung was
associated with lung hemorrhage and perinatal lethality. The
mouse Foxf1 RNase protection probe (Foxf1 cDNA nucleotides
437–816) extends from the NotI site toward the 39 end of the Foxf1
cDNA (Kalinichenko et al., 2001). The Foxf1 RNase protection
probe will therefore hybridize only with mRNA transcribed from
the wild type Foxf1 locus and will not hybridize with the targeted
Foxf1 locus containing the 59 coding region fusion with the
b-galactosidase gene.
Immunohistochemical Staining, TUNEL Apoptosis
Assay, b-Galactosidase Staining, and Transmission
lectron Microscopy
Mouse tissue was fixed, paraffin embedded, and sectioned asdescribed previously (Rausa et al., 1998). Slides were either stained R
Copyright © 2001 by Academic Press. All rightith hematoxylin/eosin for morphological examination or used
or immunohistochemical staining as described previously
Kalinichenko et al., 2001; Rausa et al., 2000). To stain for endo-
helial cell markers we used rat anti-PECAM-1 (clone MEC 13.3)
ntibody (Pharmingen, San Diego, CA) or FITC-conjugated isolec-
in B4 (Vector Labs, Burlingame, CA). For PECAM-1 staining, slides
ere pretreated with 1% trypsin in PBS for 5 min at 37°C, stained
ith anti-PECAM-1 antibody at 1:500 dilution overnight, and
isualized using biotinylated rabbit anti-rat antibody, avidin–
lkaline phosphatase complex, and BCIP/NBT substrate (Vector
abs). Slides were counterstained with nuclear fast red (Vector
abs).
For isolectin B4 staining, slides were boiled for 7 min in citrate
uffer, then blocked in 2% goat serum in PBS containing 10 mM
aCl2, 20 mM MgCl2 for 1 h, followed by staining with FITC-
conjugated isolectin B4 for 2 h at room temperature. Immunohis-
tochemical staining of lungs for proliferation cell nuclear antigen
(PCNA) and b-galactosidase enzymatic staining with 1 mg/ml
X-gal substrate (5-bromo-4-chloro-3-indolyl-b-D-galactoside) was
erformed as described previously (Kalinichenko et al., 2001).
To measure apoptosis, lung paraffin sections were dewaxed,
ehydrated, and stained for apoptosis using the TUNEL method
ith an in situ cell death detection kit from Roche Diagnostic
Indianapolis, IN) according to the manufacturer’s recommenda-
ions. Apoptotic cells were visualized using BCIP/NBT substrate
or alkaline phosphatase and then counterstained with nuclear fast
ed. Newborn lung tissue from either Low Foxf1 1/2 or wild type
ice were fixed, sectioned, and prepared for electron microscopy as
escribed previously (Rausa et al., 2000). Lung tissue sections were
hotographed using a JEOL JEM 1210 transmission electron micro-
cope (Peabody, MA) at 80 or 60 kV onto electron microscope film
Kodak, ESTAR thick base, Rochester, NY) and printed onto
hotographic paper.
Western Blot Analysis
Total protein from the lung was blotted on membrane as
described (Rausa et al., 2000) and visualized using rat monoclonal
anti-PECAM-1 (clone MEC 13.3; Pharmingen) antibody at 1:500
dilution, rat monoclonal anti-PDGF receptor a chain (clone APA5;
Pharmingen) antibody at 1:500 dilution, and mouse monoclonal
anti-actin (clone AC-40; Sigma, St. Louis, MO) antibody at 1:1000
dilution, followed by a secondary antibody directly conjugated with
HRP. Heavy chain of mouse immunoglobulin protein (Ig) was
visualized using rabbit anti-mouse Ig (Sigma) directly conjugated
with HRP. Quantitation of expression levels was determined with
.tiff files from scanned films by using the BioMax 1D program
(Kodak). The actin expression signal was used for normalization
control between different lung protein samples.
RNA Extraction and RNase One Protection Assay
Total mouse lung RNA was prepared by an acid guanidium–
thiocyanate–phenol–chloroform extraction method using RNA-
STAT-60 (Tel-Test “B” Inc., Friendswood, TX). RNase protection
assay was performed with [32P]UTP-labeled antisense RNA synthe-
sized from plasmid templates with the appropriate RNA poly-
merase as previously described (Costa et al., 1989). RNA probe
ybridization, RNase One (Promega, Madison, WI) digestion,
lectrophoresis of RNA protected fragments, and autoradiography
ere performed as described previously (Kalinichenko et al., 2001;
ausa et al., 2000). Quantitation of expression levels was deter-
s of reproduction in any form reserved.
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492 Kalinichenko et al.FIG. 1. Generation of Foxf1 knockout mice and postnatal Foxf1 1/2 survival. (A) Schematic drawing of the mouse Foxf1 gene targeting vector,
Foxf1 gene locus, and Foxf1 gene targeted locus. In the Foxf1 gene targeting vector we replaced the Foxf1 N-terminal sequences and the
inged-helix (WH) DNA binding domain (between NcoI and NotI site) with an in-frame fusion of the b-galactosidase (b-gal) gene along with
PGK-1 promoter driven neomycin (Neo) gene (used for positive selection). Also included as a negative selection for nonhomologous
recombination is PGK-1 promoter-driven herpes simplex virus thymidine kinase (HSV-TK) gene. Shown is the Foxf1 gene locus depicting the 59
flanking region, first intron (1.4 kb) and 39 flanking region (all black boxes) and the Foxf1 coding region (white box). Indicated by the dashed lines
are the regions of homologous recombination (crisscross lines) as well as Foxf1 genomic region, which is replaced by the b-gal and PGK-1 Neo
enes in the targeting vector. Location of the hybridization probe (Probe) outside of the targeting vector and the predicted hybridization bands
rom NotI and BglII digestion are indicated. (B) Southern blot analysis of ES cell DNA of wild type Foxf1 gene (1/1) and Foxf1 gene targeted locus
1/2). Identical Southern blot analysis was used to confirm targeted Foxf1 1/2 mice during the chimeric mouse breeding (data not shown). (C)
CR analysis of mouse-tail DNA from Foxf1 1/2 mouse breeding with primers described under Materials and Methods. (D–F) b-gal staining of
Day 18 Foxf1 1/2 embryonic lung depicts Foxf1 expression in smooth muscle cells of the bronchioles (Br) and alveolar endothelial cells but not
in large pulmonary arteries as identified previously in adult Foxf1 1/2 lung using immunohistochemical colocalization (Kalinichenko et al.,
2001). Day 18 Foxf1 1/2 embryonic lung was dissected, stained for b-gal enzyme activity, paraffin embedded, sectioned, and counterstained withuclear fast red. (G) Schematic representation of the postnatal survival of Foxf1 1/2 mice. Magnification: D and F, 350; E, 3100.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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493Pulmonary Hemorrhage in Newborn Foxf1 1/2 Micemined with .tiff files from scanned X-ray films by using the BioMax
1D program (Kodak). The cyclophilin hybridization signal was used
for normalization control between different lung RNA samples.
Synthesis of antisense mouse Flk-1 (gift from Janet Rossant), rat
HNF-3b, rat SP-C, rat SP-B, and mouse cyclophilin RNA probes
was described previously (Peterson et al., 1997; Ye et al., 1997).
ntisense RNA probes for mouse vascular endothelial growth
actor (VEGF), insulin-like growth factor 2 (IGF-2), endothelin B
eceptor, PECAM-1, and the transcription factors Lung Kruppel-
ike transcription factor (LKLF), T-box 2 (Tbx 2), and Tbx5 were
enerated from Atlas cDNA plasmids purchased from Clontech
Palo Alto, CA). The mouse Bmp-4 probe was obtained from
mbryonic mouse RNA (Day 9 p.c.) by RT-PCR using the following
rimers: 59-cactgtgaggagtttccatcac and 59-actgcagggctcacatcgaaag.
7 RNA polymerase was used to synthesize BMP-4 antisense probe
rom an EcoRI-digested Bmp-4 cDNA pBluescript II template. The
ouse sonic hedgehog (Shh) cDNA probe was a gift from Y. Tan
nd R. Reichel.
Mouse cDNA Array Analysis
Radioactively labeled cDNA was synthesized from lung RNA of
newborn wild type or Foxf1 1/2 littermates with low or high levels
of Foxf1 lung expression and used to hybridize to the Atlas mouse
1.2 array (Clontech) as described previously (Wang et al., 2001; Ye
et al., 1999). The hybridized Atlas cDNA arrays were then exposed
to the phosphorimaging screens for 1 or 2 days and scanned with a
storm 840 PhosphorImager. Following subtraction of background,
hybridization signals were normalized to three control genes: 40S
ribosomal protein S29 (L31609), cytoplasmic b-actin (M12481), and
lyceraldehyde-3-phosphate dehydrogenase (GADPH; M32599).
ormalized expression ratios of either High Foxf1 1/2 lung
ompared to wild type (wt) lung or Low Foxf1 1/2 lung compared
to wt lung were determined by using the AtlasImage 1.5 program
(Clontech).
RESULTS
Targeted Disruption of the Foxf1 Locus
A Foxf1 gene-targeting vector was created in which
N-terminal sequences and the winged-helix DNA binding
domain were replaced with the nuclear localizing
b-galactosidase gene and PGK-1 promoter-driven neomycin
gene (Fig. 1A). The mutant allele is expected to be fully
inactivated because the winged-helix domain is required for
both DNA recognition and nuclear localization (Hellqvist
et al., 1998; Peterson et al., 1997; Qian and Costa, 1995) and
because the remaining N-terminal Foxf1 sequences were
used in-frame with the b-galactosidase gene. Homologous
recombination of the targeting vector with the Foxf1 locus
ES cells was identified by Southern blot analysis using a
DNA probe that lies in the 39-flanking region outside of the
gene-targeting vector (Fig. 1B). Heterozygous Foxf1-targeted
ES cells were used to create germline chimeras and then
mated to develop stable heterozygous mouse strains. The
Foxf1-disrupted gene was identified in the offspring by
Southern blot analysis (data not shown) and confirmed by
PCR amplification as described under Materials and Meth-
ods (Fig. 1C). Previous b-galactosidase colocalization stud- m
Copyright © 2001 by Academic Press. All rightes with adult Foxf1 1/2 mouse lungs allowed us to
determine that Foxf1 expression was restricted to the
PECAM-1-positive alveolar endothelial cells and a-smooth
muscle actin-positive cells juxtaposed to the bronchiolar
epithelium (Kalinichenko et al., 2001). To examine Foxf1
expression in embryonic lung tissue, Day 18 p.c. Foxf1 1/2
lung was stained for b-galactosidase enzyme activity
with X-gal substrate (Blue), paraffin embedded, sectioned,
and then counterstained with nuclear fast red. The
b-galactosidase staining depicted the Foxf1 expression pat-
tern in the smooth muscle cells surrounding the bronchiole
and the alveolar endothelial cells though out the lung
parenchyma (Figs. 1D–1F). No b-galactosidase staining is
bserved in the smooth muscle and endothelial cells of the
arger pulmonary artery, suggesting that Foxf1 expression is
estricted to the smaller arterioles of the alveolar region
Fig. 1F).
Foxf1 1/2 Mice Exhibit a Perinatal Lethal
Phenotype Caused by Lung Hemorrhage and
Abnormalities in the Lung Parenchyma
Breeding studies between heterozygous Foxf1 mice pro-
uced the expected numbers of Foxf1 1/2 embryos (Table
1), suggesting that heterozygous embryos exhibited no
lethal phenotype, and we confirmed the recently reported
embryonic lethality of Foxf1 2/2 mice (Mahlapuu et al.,
2001). However, 55% of Foxf1 1/2 neonates displayed
severe breathing problems and died within several hours
after birth (Fig. 1G, Table 1). Another 5% of the Foxf1 1/2
pups died within 6 weeks after birth, while the remaining
40% of the Foxf1 1/2 mice exhibited normal life spans (Fig.
G). To examine this newborn lethal phenotype further, we
issected lungs from Foxf11/2 and wild type newborn
TABLE 1
Breeding Data from Foxf1 1/2 Mouse Crosses
Foxf1 1/1 Foxf1 1/2 Foxf1 2/2
1/1:1/2
ratio
Day 15.5 p.c. 3 (30%) 7 (70%) 0 1:2.3
Day 18.5 p.c. 13 (30%) 30 (70%) 0 1:2.3
Postnatal Day 0 46 (33%) 95 (67%) 0 1:2
Postnatal Day 1 45 (51%) 44 (49%) 0 1:1
Note. Breeding data from Foxf1 1/2 129J/Black Swiss crosses are
shown as number of embryos or newborn mice and the frequency
of occurrence of the different genotypes. Foxf1 2/2 mice died in
utero prior to Day 15.5 p.c. The observed distribution of Foxf1 1/1
to Foxf1 1/2 mice at Day 15.5 p.c. to postnatal Day 0 (P0) was not
significantly different from the expected 1:2 ratio, indicating
that Foxf1 1/2 mice do not die in utero. Significant differences in
Foxf1 1/1 to Foxf1 1/2 ratios between P0 and P1 mice indicate
that 55% of the Foxf1 1/2 newborn mice die within the first day
after birth.ice and used them for preparation of either RNA or total
s of reproduction in any form reserved.
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494 Kalinichenko et al.protein extracts and for paraffin embedding (see Materials
and Methods). RNase protection assays with the Foxf1
probe demonstrated that Foxf1 1/2 pups, which experi-
enced breathing problems and eventually died of lung
hemorrhage, exhibited significantly lower Foxf1 levels than
expected for heterozygous mice (Fig. 2A, 20% of wild type
levels). In contrast, Foxf1 1/2 newborns with normal
breathing exhibited near wild type levels of Foxf1 mRNA in
the lung, suggesting that Foxf1 expression is compensated
in a subset of heterozygous mice.
FIG. 2. Diminished expression of endothelial and epithelial marke
P-B mRNAs in lungs from newborn Low Foxf1 1/2 mice. Total R
oxf1, Flk-1, Bmp-4, Hnf3b, SP-C, SP-B, and cyclophilin mRNA by
f mRNA levels in Foxf1 1/2 lungs with respect to wild type
yclophilin levels as described under Materials and Methods. Foxf1
equal to or 90% of Foxf1 levels in wt lungs) or Low Foxf1 levels (be
ouse lung was associated with lung hemorrhage and perinatal le
oxf1 1/2 lungs. Total protein extract was prepared from the lungs
mmunoglobulin heavy chain (Ig HC), PDGFRa, and actin by W
expression of PECAM-1 and SP-B in Low Foxf1 1/2 lungs of Day 1
f Bmp-4 and Flk-1 and normal Shh levels in Low Foxf1 1/2 lungs
xpressing embryo as 50% of wt lungs.Newborn transgenic Foxf1 mice expressing 20% of wild
Copyright © 2001 by Academic Press. All rightype pulmonary levels of Foxf1 mRNA (designated as Low
Foxf1 1/2) displayed a 50% reduction in expression of the
endothelial marker PECAM-1; Foxf1 1/2 expressing near
normal levels of the mRNA (designated as High Foxf1 1/2)
displayed normal PECAM-1 levels (Figs. 2A and 2B). Fur-
thermore, similar reductions in PECAM-1 expression (Fig.
2C) were observed in lungs from Low Foxf1 1/2 Day
18.5 p.c., indicating that reduction in PECAM-1 expression
occurred prior to birth. Moreover, newborn and Day 15 p.c.
Low Foxf1 1/2 mice displayed similar reductions in pul-
Low Foxf1 1/2 lungs. (A) Diminished Flk-1, Pecam-1, BMP-4, and
was prepared from mouse lungs of newborn mice and analyzed for
se protection assay. Numbers below each panel represent average
s. Each individual sample was normalized to its corresponding
lungs were subdivided into two classes: either High Foxf1 levels
n 20 and 30% of the Foxf1 levels in wt lungs). The Low Foxf1 1/2
ty (see Fig. 4). (B) Diminished PECAM-1 protein in newborn Low
ild type and Foxf1 1/2 newborn mice and analyzed for PECAM-1,
rn blot analysis. (C) RNase protection assay shows diminished
.c. embryos. (D) RNase protection assay shows reduced expression
y 15 p.c. embryos. For Day 15 Foxf11/2 lung, we classified a highrs in
NA
RNa
lung
1/2
twee
thali
of w
este
8.5 p
of Damonary levels of Flk-1 (VEGF receptor 2). However, the
s of reproduction in any form reserved.
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495Pulmonary Hemorrhage in Newborn Foxf1 1/2 Micedecline in pulmonary Flk-1 levels was not evident in lungs
from High Foxf1 1/2 mice (Figs. 2A and 2D). Given that
Flk-1 and VEGF are known to influence formation of the
pulmonary vasculature, we assessed the expression of the
endothelial markers by immunohistochemistry. Newborn
lungs were stained with monoclonal anti-PECAM-1 anti-
body (Sheibani et al., 1999) or isolectin B4 from Griffonia
Simplicifolia (Akeson et al., 2000). The levels and distribu-
tion of PECAM staining were decreased in lungs from the
Low Foxf1 1/2 mice (Figs. 3C, 3D, and 3H), compared to
hat of either wild type (Figs. 3A and 3G) or High Foxf1 1/2
ungs (Fig. 3B). Interestingly, the larger Foxf1 1/2 pulmo-
ary vessels, which normally do not express Foxf1 (Fig. 1F),
xhibited wild type PECAM-1 staining, indicating that the
ndothelial vascular defect was restricted to the alveolar
apillaries and arterioles (Figs. 3C and 3D). This result
uggests that reduced Foxf1 levels in the developing Low
oxf1 1/2lung lead to defects in pulmonary vasculogenesis
r angiogenesis.
Moreover, pulmonary epithelial cell expression of
NF-3b and SP-C were normal in newborn Low Foxf1 1/2
ungs. In contrast, diminished expression of SP-B was found
n both newborn and Day 18 p.c. Low Foxf1 heterozygous
ungs (Figs. 2A and 2C). Interestingly, both newborn and
ay 15 p.c. Low Foxf1 1/2 lungs exhibited diminished
xpression of Bmp4 (Figs. 2C and 2D), a protein considered
mportant for lung branching morphogenesis and develop-
ent of the pulmonary vasculature (Bellusci et al., 1996;
eaver et al., 1999). In contrast, Shh expression was similar
in wild type and both High and Low Foxf1 1/2 embryonic
lungs on Day 15 p.c., suggesting that Shh does not play a
critical role in the Low Foxf1 1/2 mouse phenotype (Fig.
2D). Western blot analysis demonstrated that the Low
Foxf1 1/2 perinatal lungs displayed a slightly elevated
xpression of platelet-derived growth factor receptor a
(PDGFRa) and an aberrantly high level of immunoglobulin
Ig) heavy chain proteins (Fig. 2B). The increase in pulmo-
ary Ig heavy chain levels suggested that either plasma or
lood leaked into the lung parenchyma of the Low Foxf1
/2 newborn mice.
Hematoxylin and eosin (H & E) staining of the newborn
ow Foxf1 1/2 lungs revealed extensive pulmonary hem-
orrhage with red blood cells present in peripheral airspaces
and in bronchioles (Fig. 4; compare 4A and 4B with 4E and
4F). In contrast, the High Foxf1 1/2 lungs did not exhibit
lung hemorrhage, indicating that the levels of pulmonary
Foxf1 may be contributing to this phenotype (Figs. 4C and
4D). Lung hemorrhage was not observed in Day 18 p.c. Low
Foxf1 1/2 embryos (data not shown), indicating that the
hemorrhaging phenotype was concomitant with the in-
creased pulmonary arterial blood flow that occurs following
birth. Furthermore, the Low Foxf1 1/2 lungs exhibited
diminished sacculation of the lung periphery, indicating
that they failed to undergo differentiation of the terminal
airspaces (Figs. 4E and 4F). A less-severe defect in septation
of the lung periphery was observed in the High Foxf1 1/2
mice (Figs. 4C and 4D). p
Copyright © 2001 by Academic Press. All rightDisruption of Mesenchymal–Epithelial Cellular
Interfaces and Increased Apoptosis in Lungs
of the Low Foxf1 1/2 Mice
Because the Low Foxf1 1/2 lungs exhibit defects in the
structure of the pulmonary vasculature and the lung periph-
ery, transmission electron microscopy (TEM) was used to
examine the interface between the mesenchymally derived
endothelial cells (EC) and the endodermally derived Type I
epithelial cells in wild type and Low Foxf1 1/2 newborn
lungs. Normal tight junctions were noted between endothe-
lial and Type I cells in polar capillaries in wild type mice
(Figs. 5A and 5C). In contrast, capillaries from the Low
Foxf1 1/2 mice exhibited disruption of tight junctions
between endothelial and Type I cells, and in some cases
edema was observed between the two cell types (Figs. 5A
and 5B). At higher magnification, tight junctions in wild
type mice were noted to possess uniform basement mem-
brane extracellular matrix (ECM) deposition, whereas ECM
deposition was thinned in Foxf1 1/2 mice and tight junc-
tions were disrupted (Figs. 5C and 5D). Defects in the tight
junctions and ECM deposition were associated with pulmo-
nary hemorrhage in the lung periphery of Low Foxf1 1/2
mice.
Because Foxf1 is expressed in the peribronchiolar smooth
muscle cells (Kalinichenko et al., 2001), we used TEM to
examine the interface between bronchiolar smooth muscle
and epithelial cells in wild type and Low Foxf1 1/2
newborn mice. Although the smooth muscle cell (SMC)
layer in wild type mice was closely associated with overly-
ing bronchiolar epithelium (BE), disruption of both the SMC
layer and the basement membrane ECM was noted in the
Low Foxf1 1/2 mice (Figs. 6A and 6B). Similarly, examina-
tion of the Low Foxf1 1/2 arterioles showed that the SMC
layer underlying the arteriolar endothelium (EC) contained
large vesicular inclusions and the basement membrane
ECM was disrupted (Figs. 6C and 6D). This observed defect
in mesenchyme–epithelial interfaces in the Low Foxf1 1/2
mice may therefore cause pulmonary hemorrhage in the
newborn mice.
Apoptosis was assessed in newborn lungs of the Low and
High Foxf1 1/2 mice using the TUNEL assay. Rare apo-
tosis was observed in newborn lungs from either wild type
r High Foxf1 1/2 mice (Figs. 7A and 7B), whereas numer-
us apoptotic cells were visible throughout the lung paren-
hyma of the newborn Low Foxf1 1/2 mice (Figs. 7C and
D). The increased cellular apoptosis may also contribute to
isruption of tight junctions and lead to the observed lung
emorrhage seen in the Low Foxf1 1/2 mice. Furthermore,
onsistent with the defective formation of the bronchiolar
MC layer, we observed extensive apoptosis of the smooth
uscle cells underlying the bronchiolar epithelial cells (Fig.
E). An increase in apoptosis was also observed in the small
rterial SMC in Low Foxf1 1/2 newborn lungs (Fig. 7F).
ncreased apoptosis within the supportive SMC layer sur-
ounding the bronchioles and arterioles was associated with
ulmonary hemorrhage and leakage of red blood cells in the
s of reproduction in any form reserved.
496 Kalinichenko et al.FIG. 3. Reduced pulmonary vasculature in the alveolar region of Foxf1 1/2 mice with low Foxf1 expression. Microtome sections of
paraffin-embedded lungs were prepared from newborn wild type (A, E, G) or Foxf1 1/2 mice expressing either High (B) or Low (C, D, F, H)
Foxf1 mRNA. Endothelial cells were detected by immunohistochemical staining with either anti-PECAM-1 Antibody (A–F) or
FITC-conjugated isolectin B4 from Griffonia Simplicifolia (G, H). PECAM-1 (C, D) staining was decreased in the lung parenchyma of Low
Foxf1 1/2 lungs compared to that of either High Foxf1 1/2 (B) or wild type (A) mice. PECAM-1 staining was similar in large pulmonary
blood vessels from either Low Foxf1 1/2 or wild type mice (E, F). Endothelial staining with FITC-conjugated isolectin B4 was also reduced
in Low Foxf1 1/2 (H) compared to that of wild type lungs. Magnification: A and B, 325; C–H, 3100.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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497Pulmonary Hemorrhage in Newborn Foxf1 1/2 Micelumen of the Low Foxf1 1/2 bronchioles (Fig. 6B). Equiva-
ent immunohistochemical staining with PCNA antibody
as observed in newborn lungs of wild type and Low Foxf1
/2 mice (Figs. 7G and 7H), indicating that the Low Foxf1
/2 lungs did not exhibit altered cellular proliferation
compared to that of wild type.
cDNA Expression Array Identified Altered
Expression of Genes Associated with the
Foxf1 1/2 Lung Phenotype
Differential hybridization of cDNA arrays was used to
FIG. 4. Pulmonary hemorrhage in newborn Low Foxf1 1/2 mice.
ungs with either high (C, D) or low (E, F) Foxf1 mRNA levels were
parenchyma and airspaces of Low Foxf1 1/2 lungs (expressing low
(WT) or High Foxf1 1/2 lungs (expressing high Foxf1 levels). Magidentify genes whose altered expression was associated
Copyright © 2001 by Academic Press. All rightith the Foxf1 1/2 lung phenotype. Radioactive cDNA
repared from either wild type or Foxf1 1/2 (Low or High)
newborn lungs was hybridized to the mouse Atlas 1.2
Expression cDNA Array Blot and phosphorimager files were
analyzed by the AtlasImage 1.5 program (Clontech; see
Materials and Methods). Because lung hemorrhage was
associated with low levels of Foxf1, we used RNA from
newborn Foxf1 1/2 lungs exhibiting either high or low
Foxf1 levels for comparisons with wild type lungs. Analysis
of the Atlas 1.2 Expression cDNA Array Blot (Table 2)
confirmed the High and Low expression levels of Foxf1 in
heterozygous lungs as determined by RNase protection
otome sections of paraffin-embedded wild type (A, B) or Foxf1 1/2
ed with hematoxylin–eosin. Red blood cells are noted in the lung
ls of Foxf1). No hemorrhage was detected in the lungs of wild type
tion: A, C and E, 325; B, D, and F, 3158.Micr
stain
leveassays (Fig. 8). Furthermore, we identified genes whose
s of reproduction in any form reserved.
498 Kalinichenko et al.FIG. 5. Transmission electron micrographs of alveolar capillaries from wild type or Low Foxf1 1/2 newborn lungs. Ultrastructural
analysis of endothelial cell (EC)–Type I Cell (TIC) interactions in wild type (WT) and Low Foxf1 1/2 newborn lungs. Wild type capillary
(A) with red blood cell (RBC) and Low Foxf1 1/2 capillary (B) showing disruption of basement membrane and edema (*) between EC and
TIC. At higher magnification, WT endothelial cells (C) exhibit tight junctions (arrow) and uniform basement membrane extracellular
matrix deposition (arrowheads). In capillaries from Foxf1 mice, tight junctions (arrow) and basement membranes (arrowhead) were
disrupted (D) and the ECM was abnormal (*). Bars: A and B, 500 nm; C and D, 200 nm.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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499Pulmonary Hemorrhage in Newborn Foxf1 1/2 MiceFIG. 6. Transmission electron micrographs of bronchioles and arterioles from wild type or Low Foxf1 1/2 newborn lungs. Ultrastructural
morphology of bronchiolar (A, B) and arteriolar (C, D) region in wild type (WT) and Foxf1 1/2 newborn lungs are shown. In bronchioles
rom wild type mice (A), the smooth muscle cell (SMC) layer (arrows) is in tight association with overlying bronchiolar epithelium (BE),
hereas in Foxf1 mice, SMC layers (arrows) in the bronchioles and extracellular matrix in basement membranes are disrupted (*). Note the
resence of erythrocytes in the lumen of the bronchioles. In Low Foxf1 mice, the, SMC layer underlying arteriolar (C) endothelial cells (EC)
ontains large vesicular inclusions (arrows) and disrupted basement membrane extracellular matrix (*) when compared to SMC basement
embrane of wild type arterioles (C, arrowheads). Bars: A and B, 5 mm; C and D, 2 mm.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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500 Kalinichenko et al.FIG. 7. Apoptosis and PCNA staining in lungs of newborn Low Foxf1 1/2 mice. Lung sections from newborn wild type (A), High Foxf1
1/2 mice (B), or Low Foxf1 1/2 mice (C–F) were used for TUNEL assay to detect apoptotic cells. Only sporadic apoptotic cells (stained
rown, indicated by arrows) were detected in wild type and High Foxf1 1/2 lungs (A, B), whereas apoptotic cells were observed in the lung
parenchyma (C, D), muscle cell layers underlying bronchiolar epithelial cells (E), and small arterioles (F). Lung sections from newborn wild
type (G) or Low Foxf1 1/2 mice (H) were stained with PCNA antibody as described previously. No difference was observed in PCNA
taining between newborn wild type and Low Foxf1 1/2 lungs. Arrows indicate either apoptotic cells (A–F) or PCNA staining cells (G, H).agnification: A–C, G, H, 325; D, 3100; E and F, 3158. Abbreviations: bronchiole, Br; arteriole, Ar.
Copyright © 2001 by Academic Press. All rights of reproduction in any form reserved.
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501Pulmonary Hemorrhage in Newborn Foxf1 1/2 Miceexpression was diminished either in only Low Foxf1 1/2
lungs (Table 2, italicized entries) or in both types of Foxf1
/2 lungs (Table 2, boldface entries). A subset of mRNAs,
hose expression was selectively decreased in the Low
oxf1 1/2 lungs (Table 2), included the mammalian
rachyury homologs of T-box 2 (Tbx2) through Tbx5 tran-
cription factors. Like Foxf1, these mRNAs are expressed in
he developing lung mesenchyme (Chapman et al., 1996).
he transcription factor Lung Kruppel-like Factor (LKLF),
hich is required for normal lung development (Wani et al.,
999), and the basic helix–loop–helix (bHLH) SEF2 genes
ere selectively reduced in the lungs from Low Foxf1 1/2
ice (Table 2). RNase protection assays confirmed the
elective reduction in Tbx-2, Tbx-5, and LKLF transcription
actors in the hemorrhagic newborn Foxf1 1/2 lungs (Fig.
A). These results suggest that diminished Foxf1 levels in
he Low Foxf1 1/2 lung may contribute to reduced expres-
ion of these genes. An alternative explanation for their
ecreased expression may result from a reduction in the
umber of endothelial and smooth muscle cells, which is
ikely caused by apoptosis of these cells in the Low Foxf1
/2 lungs.
The Foxf1 1/2 lungs also displayed a 60–70% reduction
n expression of the endothelial PAS domain protein 1
EPAS1, Table 2), a protein required for proper vascular
emodeling (Peng et al., 2000; Tian et al., 1997). We also
TABLE 2
Differential Gene Expression in Foxf1 1/2 Lungs Using cDNA Ar
Gene name GenBank Acce
Transcription factors and DNA-binding proteins
Forkhead Box F1 (HFH8; Freac-1) L35
T-Box Protein 2 (Tbx2; Brachyury homolog) U15
Tbx3 U57
Tbx4 U57
Tbx5 U57
Endothelial PAS Domain Protein 1 (EPAS1) U81
Nuclear LIM Interactor (NLI) U69
Lung Kruppel-like Factor U25
Helix–loop–helix SEF2 X91
Zinc Finger/Homeodomain deltaEF1 D76
Receptors
Endothelin B Receptor U32
D-factor/LIF Receptor D26
Extracellular cell signaling and communication
Insulin-like Growth Factor II (IGF-II; IGF2) M14
Vascular Endothelial Growth Factor (VEGF) M95
Angiotensin Converting Enzyme (ACE) J049
Note. Total lung RNA was isolated from either newborn Foxf1 1/
synthesized from 5 mg RNA from newborn lung, was hybridized to M
analysis. Atlas 1.5 was used to analyze the gene expression level fo
increase of High Foxf1 1/2 (high Foxf1-expressing lung) versus wt
lung) versus wt lung (Low Foxf1 1/2/wt lung). Italicized entries i
lung; boldface entries indicate genes whose expression is diminishbserved a two-fold reduction in pulmonary Foxf1 1/2
Copyright © 2001 by Academic Press. All rightxpression of zinc finger/homeodomain d-crystallin
enhancer/E2-box factor 1 (dEF1, Table 2), an E2-box (CAC-
TG) binding transcriptional repressor that has been impli-
ated in skeletal development (Funahashi et al., 1993;
akagi et al., 1998). Reduced expression of dEF1 in newborn
Foxf1 1/2 mouse lungs suggests that its decrease may
contribute to defective lung maturation found in the Foxf1
heterozygous mice. Interestingly, a 50% decrease in expres-
sion of the vasculogenesis regulator VEGF was found in the
Foxf1 1/2 lungs (Table 2), a result confirmed by RNase
rotection assay (Figs. 8A and 8B). VEGF and Flk-1 (VEGF
eceptor 2) were reduced in the developing Low Foxf1 1/2
ungs, a finding that may explain the abnormal vascular
evelopment seen in these mice. Furthermore, an 80%
eduction in expression of Endothelin B Receptor was
bserved in the lungs from Low Foxf1 1/2 mice (Table 2),
a finding confirmed by RNase protection assay (Figs. 8A and
8B). Interestingly, angiotensin converting enzyme (ACE)
mRNA was decreased in the newborn Foxf1 1/2 lungs,
suggesting functional defects in the Foxf1 1/2 pulmonary
endothelial cells. Moreover, the Low Foxf1 1/2 lungs
displayed diminished expression of insulin-like growth fac-
tor 2 (IGF-2; Table 2); however, RNase protection assays
demonstrate that this decrease is restricted to newborn
lungs, suggesting that its reduced expression may be a
nalysis
Number High Foxf1 1/2/wt lung Low Foxf1 1/2/wt lung
1.2 0.3
1.1 0.4
1.0 0.5
0.8 0.5
1.3 0.4
0.4 0.3
0.5 0.3
1.0 0.5
1.0 0.4
0.6 0.4
1.1 0.2
0.2 0.3
0.8 0.5
0.6 0.4
0.5 0.4
gh and low Foxf1 levels) or wild type (wt) mice. Radioactive cDNA,
e 1.2 cDNA array (Clontech) and then exposed for phosphorimager
ng normalization to control housekeeping genes, expressed as fold
(High Foxf1 1/2 wt lung) or Low Foxf1 1/2 (low Foxf1-expressing
te genes whose expression is diminished only in Low Foxf1 1/2
both types of Foxf1 1/2 lungs.ray A
ssion
949
566
328
329
330
983
270
096
753
432
329
177
951
200
46
2 (hi
ous
llowi
lung
ndicaconsequence of the neonatal pulmonary hemorrhage.
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502 Kalinichenko et al.DISCUSSION
Mice homozygous for Foxf1 null mutation die in utero
because of defects in differentiation of extraembryonic and
lateral mesoderm-derived tissues (Mahlapuu et al., 2001). In
this study, we demonstrate that 55% of the newborn Foxf1
1/2 mice die from severe lung hemorrhage, associated with
malformation of the vascular–epithelial interface in lung
parenchyma. Lung malformations and pulmonary hemor-
rhage were observed in mice expressing Foxf1 mRNA at
levels less than 50% of wild type mRNA (designated Low
Foxf1 1/2 mice), suggesting that wild type pulmonary
expression of Foxf1 is required for normal lung develop-
ment. Pulmonary hemorrhage was not observed in a subset
of newborn Foxf1 1/2 mice that possessed wild type lung
levels of Foxf1 (designated as High Foxf1 1/2 mice). The
observed abnormalities in early alveologenesis and in for-
mation of the pulmonary vasculature suggest that wild type
levels of Foxf1 are necessary for proper alveolar formation
and formation and integrity of blood vessels in pulmonary
tissues. Large pulmonary vessels were not affected in the
Low Foxf1 1/2 mice, consistent with the previous findings
demonstrating that Foxf1 expression was confined to
smaller pulmonary vessels (Kalinichenko et al., 2001). Al-
though the mechanisms involved in compensation of the
wild type Foxf1 allele for the loss of expression from the
FIG. 8. RNase protection assay to validate genes identified by cD
or Foxf1 1/2 mouse lungs of newborn mice (A) or Day 18.5 p.c. mo
endothelin B receptor, insulin growth factor-2 (IGF-2), the transcript
vascular endothelial growth factor (VEGF), and cyclophilin mRNAs
in Foxf1 1/2 lungs (expressing either High or Low levels of Foxf1targeted locus remain unknown, the High Foxf1 1/2 mice S
Copyright © 2001 by Academic Press. All rightavoided lung hemorrhage and possessed normal life spans.
This result suggests that restoration of wild type lung
expression of Foxf1 in heterozygous lung is essential for
pulmonary homeostasis and survival. Interestingly, the
diffuse pulmonary bleeding observed in the Low Foxf1 1/2
ice resembles idiopathic pulmonary hemorrhage seen in
reterm newborn infants, a relatively common disorder
ffecting premature infants in the immediate newborn
eriod (Rezkalla and Simmons, 1995). Whether mutations
r dysregulation of Foxf1 underlies idiopathic pulmonary
emorrhage in preterm infants remains to be discerned.
In addition to the disruption in alveolar maturation and
ndothelial vasculature in the Low Foxf1 1/2 lungs, we
ound several other defects that contribute to the severe
ung hemorrhage. First, disruption in the alveolar capillar-
es of the Low Foxf1 1/2 lungs is associated with loss of
ight junctions between endothelial and Type I epithelial
ell interfaces, which may allow plasma to leak between
he interfaces of the alveolar cells, thus causing lung edema.
econd, we observed a significant increase in apoptosis in
he lung parenchyma and bronchiolar smooth muscle cells
SMC), the latter of which diminishes the SMC layer
nderlying bronchiolar epithelial cells that may contribute
o the loss of tissue integrity leading to pulmonary hemor-
hage in the Foxf1 1/2 mice at birth. RNase protection
assays demonstrate that, while expression of HNF-3b and
rray in Foxf1 1/2 lungs. Total RNA was prepared from wild type
mbryos (B). RNase protection assays were performed to determine
actors T-box 2 (Tbx-2), Tbx-5, and Lung Kruppel-like Factor (LKLF),
mbers below each panel represent average of relative mRNA levels
h respect to wild type lungs.NA a
use e
ion f
. NuP-C is normal, SP-B mRNA was reduced 40% in severely
s of reproduction in any form reserved.
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503Pulmonary Hemorrhage in Newborn Foxf1 1/2 Miceaffected Foxf1-deficient mice. Given that SP-B is required
or respiratory function at birth (Clark et al., 1995), reduc-
tion in SP-B may contribute to respiratory failure and
pulmonary hemorrhage. Exposure of SP-B 1/2 mice to
hyperoxia demonstrated increased severity of pulmonary
edema, hemorrhage and inflammation, increased perme-
ability, and serum protein leakage into alveolar space (To-
kieda et al., 1999). These studies suggest that in combina-
ion with defects in lung morphogenesis, reduced
xpression of SP-B in newborn Low Foxf1 1/2 mice may
influence respiratory failure and pulmonary hemorrhage in
the Foxf1 1/2 mice.
The abnormalities in lung structure were more severe in
Low Foxf1 1/2 than in High Foxf1 1/2 mice and selective
hanges in gene expression were observed in the former.
ecreases in the Bmp4 gene, whose appropriate expression
s essential for lung branching morphogenesis (Bellusci et
l., 1996; Weaver et al., 1999), and VEGF receptor Flk-1,
hich is required to mediate vasculogenesis (Shalaby et al.,
995), were observed in lungs of the Low Foxf1 mice. In
ormal lungs, sufficient levels of Bmp-4 and Flk-1 are
ssential for the canalicular stage of lung development
Days 16.6–17.4 p.c.), which is coincident with formation of
he peripheral airspaces and differentiation of the pulmo-
ary parenchyma that accompany formation of the pulmo-
ary vasculature (Warburton et al., 2000).
Likewise, continued expression of these genes is required
or vasculogenesis in the final terminal sac stage of lung
evelopment (Day 17.5 p.c. to postnatal Day 5). This
evelopmental period was characterized by a coordinated
ncrease in pulmonary terminal sac formation and vessel
ormation that is coincident with formation of terminal
irspaces and alveoli, during which alveolar epithelial Type
and II cells differentiate (Warburton et al., 2000). Ectopic
xpression of Bmp-4 alters branching morphogenesis of the
erminal sac stage of lung development (Bellusci et al.,
996; Weaver et al., 1999). The observation that levels of
mp-4 mRNA are decreased in Low Foxf11/2 mice sug-
ests that the reduction in Bmp-4 may contribute to the
tructural abnormalities seen in the Low Foxf1 1/2 mice.
he findings that the Bmp-4 promoter contains binding
ites for Foxf1 (Peterson et al., 1997) and that significant
eduction in mesodermal expression of Bmp4 was found in
oxf1 2/2 embryos provide further support for this concept
Mahlapuu et al., 2001). Although VEGF mRNA was de-
reased approximately 50% in both High and Low Foxf1
/2 lungs, the normal pattern of endothelial staining for
ECAM in the High Foxf1 lung suggests that reduction in
EGF alone is not sufficient to explain the abnormalities of
ascular structure and pulmonary hemorrhage in the lungs
f the Low Foxf1 1/2 mice.
Our data suggest that, in combination with reduced
ulmonary levels of VEGF, the selective reduction of Flk-1
VEGFR-2) mRNA in lung contributes to the observed
bnormalities in the pulmonary vasculature (Fig. 3). Re-
uced expression of Flk-1 in the lung mesenchyme was also
bserved in Foxf1 2/2 embryos, suggesting that the Flk-1
Copyright © 2001 by Academic Press. All rightene is regulated by Foxf1 (Mahlapuu et al., 2001). More-
ver, Fgf10 2/2 mice die immediately after birth because of
disruption of pulmonary branching morphogenesis and this
phenotype is coincident with severe reductions in expres-
sion of Shh and Bmp4 (lung endoderm) and mesenchymally
derived Wnt2 (Sekine et al., 1999). In combination with in
vitro lung culture studies, analysis of the Fgf10 2/2 mice
revealed that FGF10 is involved in the induction of Shh,
Bmp4, and Wnt2 signaling molecules, all of which are
essential for lung development (Sekine et al., 1999; Weaver
et al., 2000). The fact that Low Foxf11/2 lungs express
normal levels of Shh, but reduced levels of Bmp-4, suggests
that the Foxf1 transcription factor is downstream of FGF-10
in the signaling pathway.
We also observed a selective decrease of Lung Kruppel-
like factor (LKLF) that may also contribute to increased
severity of the lung malformation characteristic of the Low
Foxf1 1/2 mice (Table 2 and Fig. 8). Because LKLF 2/2
mutations are embryonic lethal (Wani et al., 1998), LKLF
2/2 ES cells were injected into wild type C57B1/6 mouse
blastocysts to create chimeric mice and demonstrate that
the LKLF-deficient cells do not contribute to the formation
of the lung (Wani et al., 1999). Several mice exhibiting high
LKLF 2/2 chimerism died shortly after birth from breath-
ing defects and displayed lungs that were arrested in the late
canalicular stage of lung development with deficient alveo-
lar maturation and mesenchymal branching (Wani et al.,
1999). The fact that these mice exhibit defects in lung
branching morphogenesis suggests that diminished pulmo-
nary levels of LKLF may be contributing to the observed
defects in the Low Foxf11/2 lungs. Expression of the
Brachyury transcription factors Tbx2, Tbx3, Tbx4, and
Tbx5 was also selectively reduced in the Low Foxf11/2
lungs (Table 2 and Fig. 8). Although Tbx2–Tbx5 transcrip-
tion factors have been implicated in limb development
(Gibson-Brown et al., 1998), their expression pattern is also
similar to that of Foxf1 in the lung mesenchyme (Chapman
et al., 1996). The finding that Tbx2–Tbx5 mRNAs are
reduced in the Low Foxf1 1/2 mice suggests that Foxf1
may regulate the Tbx transcription factors. Whether
changes in Tbx factors also contribute to the lung defects
observed in the Foxf1-deficient mice remains to be discov-
ered.
In summary we describe a heterozygous lethal phenotype
in which 55% of the newborn Foxf1 1/2 mice die from
severe lung hemorrhaging. The severity of lung malforma-
tion and pulmonary hemorrhage correlated with Foxf1
levels. Abnormalities in lung morphogenesis in Low Foxf1
1/2 lungs are consistent with defective alveologenesis and
abnormalities in the formation of peripheral pulmonary
vasculature. Pulmonary hemorrhage correlated with the
severity of morphologic abnormalities in endothelial and
smooth muscle cells in the pulmonary vascular tissue,
disruption of the mesenchymal–epithelial cell interfaces,
increased apoptosis in the lung mesenchyme, and reduced
surfactant protein B (SP-B) mRNA, all of which may con-
tribute to the pathogenesis of pulmonary hemorrhage.
s of reproduction in any form reserved.
504 Kalinichenko et al.Moreover, the Foxf1 1/2 lung defect is accompanied by
reduced expression of VEGF, Flk-1, and Bmp-4 as well as the
transcription factors Tbx2–Tbx5 and Lung Kruppel-like
Factor (LKLF). Finally, idiopathic pulmonary hemorrhage is
a relatively common but life-threatening disorder affecting
approximately 5% of extremely preterm infants. Whether
functional or developmental deficiency of Foxf1 activity, or
its targets, contributes to the pathogenesis of neonatal
pulmonary hemorrhage remains to be discerned.
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